Dosing Recommendations of Aripiprazole Depot with Strong Cytochrome P450 3A4 Inhibitors: A Relapse Risk

A 50-year-old male patient with comorbid human immunodeficiency virus developed a relapse of bipolar disorder after a switch from oral aripiprazole 10 mg/day to intramuscular aripiprazole depot 200 mg every 28 days plus oral aripiprazole 5 mg/day. The patient was concomitantly taking lopinavir, saqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Martina, Roll, Sibylle C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005780/
https://www.ncbi.nlm.nih.gov/pubmed/27747685
http://dx.doi.org/10.1007/s40800-016-0027-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005780/
https://www.ncbi.nlm.nih.gov/pubmed/27747685
http://dx.doi.org/10.1007/s40800-016-0027-7

Ejemplares similares